Development and Characterization of Liposomal formulation for the effective treatment of Colon cancer
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
prepare and evaluate liposomal formulation against HeLa
newlineand CT26 carcinoma cell line by MTT assay.
newlineMaterial and methods: The non-targeted and targeted liposome formulations were prepared with
newlinedifferent composition of ingredients by thin film hydration technique. The liposomal formulation was
newlinecharacterized for particle size, zeta potential, encapsulation efficiency, SEM and In-vitro release. The
newlineliposome formulation with negative zeta potential used for the anticancer screening by ex-vivo study
newlineon HeLa and CT-26 carcinoma cell line by MTT assay.
newlineThe non targeted liposome formulation F5 has shown the particle size 187.23 nm with zeta
newlinepotential of -23.40 mV. The D-LP formulation has the particle size 142.23 nm with zeta potential of -
newline21.7 mV and Targeted liposome (F-D-LP) has shown the particle size 158.20 nm with zeta potential -
newline27.2 mV. The colon cancer cell line HeLa and CT26 were selected for anticancer screening by MTT
newlineassay and result data suggested the IC50 for DOX, F5, D-LP and F-D-LP were 174.98, 170.54, 145.25
newlineand 63.52 and#956;M, respectively in HeLa cell line. IC50 for DOX, F5, D-LP and F-D-LP were 22.91, 21.90,
newline18.54 and 4.02 and#956;M, respectively in CT-6 cell line.
newlineThe Ex-vivo cytotoxicity study suggested that F-D-LP shown higher toxicity on HeLa and
newlineCT-6 cell line as compare to DOX, F5 and D-LP. The growth inhibition effect of F-D-LP was
newlinesignificantly stronger than DOX and non-targeted liposome (F5 and D-LP) on HeLa and CT-6 cell
newlineline. DOX encapsulated in F-D-LP showed the lowest IC50, which means a significantly reduced dose
newlineof drug in the targeted liposome with high effectiveness. The result concluded that targeted liposome
newline(F-D-LP) enhanced drug delivery and accumulation in cancer cells
newline